Drug makers spend 6.3% of revenue on R&D in first quarter

Details of drug company spending, revealed by Yakup com., showed that the country's 51 pharmaceutical companies on average spent 6.32 percent of their revenue on research and development (R&D) in the first half, much less than the 20 percent overseas pharmaceutical firms spend ― on research and developing new medicine.

The report comes at a time when the government has issued numerous warnin...